Guangzheng Eye Hospital Group Co.,Ltd. (SHE:002524)
China · Delayed Price · Currency is CNY 3.590
-0.020 (-0.55%)
Nov 3, 2026, 9:45 AM CST
SHE:002524 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 776.56 | 848.01 | 859.88 | 1,041 | 743.26 | 1,027 |
Other Revenue | 37.17 | 37.17 | 32.96 | 33.85 | 24.19 | 17.65 |
| 813.73 | 885.18 | 892.84 | 1,075 | 767.44 | 1,044 | |
Revenue Growth | -5.11% | -0.86% | -16.94% | 40.06% | -26.52% | 13.40% |
Cost of Revenue | 493.26 | 565.92 | 566.61 | 700.04 | 576.9 | 712.08 |
Gross Profit | 320.46 | 319.26 | 326.24 | 374.86 | 190.55 | 332.4 |
Selling, General & Admin | 270.4 | 282.75 | 324.03 | 325.9 | 276.67 | 342.85 |
Research & Development | 3.38 | 4.13 | 3.58 | 4.97 | 0.86 | 3.96 |
Other Operating Expenses | 2.44 | 4.21 | 3.99 | 4.51 | 4.51 | -14.7 |
Operating Expenses | 277.6 | 290.66 | 332.39 | 338.03 | 283.81 | 326.41 |
Operating Income | 42.86 | 28.6 | -6.15 | 36.83 | -93.26 | 5.99 |
Interest Expense | -30.37 | -33.96 | -38.38 | -38.75 | -36.34 | -37.71 |
Interest & Investment Income | 20.67 | 9.98 | 15.4 | 1.48 | 0.89 | 81.35 |
Other Non Operating Income (Expenses) | -4.47 | -1.65 | -2.46 | -1.67 | -0.95 | -6.4 |
EBT Excluding Unusual Items | 28.69 | 2.97 | -31.59 | -2.12 | -129.67 | 43.22 |
Impairment of Goodwill | -1.55 | -1.55 | -134.63 | -1.26 | -138.63 | -5.74 |
Gain (Loss) on Sale of Investments | - | - | - | - | -20.51 | - |
Gain (Loss) on Sale of Assets | 1.04 | -0.2 | 5.02 | 1.7 | 1.04 | 7.2 |
Asset Writedown | 0.65 | -0.07 | -0.04 | -0.08 | -0.09 | -0.04 |
Other Unusual Items | -2.8 | -2.8 | 0.15 | 9.68 | 212.28 | 0.3 |
Pretax Income | 26.04 | -1.66 | -161.09 | 7.91 | -75.58 | 44.94 |
Income Tax Expense | 22.65 | 18.01 | 13.89 | -1.83 | 2.22 | 8.49 |
Earnings From Continuing Operations | 3.38 | -19.67 | -174.98 | 9.75 | -77.8 | 36.44 |
Minority Interest in Earnings | -0.4 | 0.17 | 0.32 | -0.49 | -0.42 | 0.48 |
Net Income | 2.98 | -19.5 | -174.65 | 9.26 | -78.22 | 36.93 |
Net Income to Common | 2.98 | -19.5 | -174.65 | 9.26 | -78.22 | 36.93 |
Net Income Growth | - | - | - | - | - | -13.31% |
Shares Outstanding (Basic) | 514 | 487 | 514 | 463 | 521 | 501 |
Shares Outstanding (Diluted) | 514 | 487 | 514 | 463 | 521 | 517 |
Shares Change | - | -5.11% | 11.01% | -11.26% | 0.81% | 0.17% |
EPS (Basic) | 0.01 | -0.04 | -0.34 | 0.02 | -0.15 | 0.07 |
EPS (Diluted) | 0.01 | -0.04 | -0.34 | 0.02 | -0.15 | 0.07 |
EPS Growth | - | - | - | - | - | -12.50% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 130.43 | 95.69 | 43.32 | 15.48 | 83.61 | 92.91 |
Free Cash Flow Per Share | 0.25 | 0.20 | 0.08 | 0.03 | 0.16 | 0.18 |
Gross Margin | 39.38% | 36.07% | 36.54% | 34.87% | 24.83% | 31.82% |
Operating Margin | 5.27% | 3.23% | -0.69% | 3.43% | -12.15% | 0.57% |
Profit Margin | 0.37% | -2.20% | -19.56% | 0.86% | -10.19% | 3.54% |
Free Cash Flow Margin | 16.03% | 10.81% | 4.85% | 1.44% | 10.90% | 8.89% |
EBITDA | 72.45 | 59.61 | 26.76 | 73.13 | -52.89 | 55.01 |
EBITDA Margin | 8.90% | 6.73% | 3.00% | 6.80% | -6.89% | 5.27% |
D&A For EBITDA | 29.59 | 31.01 | 32.91 | 36.3 | 40.38 | 49.02 |
EBIT | 42.86 | 28.6 | -6.15 | 36.83 | -93.26 | 5.99 |
EBIT Margin | 5.27% | 3.23% | -0.69% | 3.43% | -12.15% | 0.57% |
Effective Tax Rate | 87.01% | - | - | - | - | 18.90% |
Revenue as Reported | 813.73 | 885.18 | 892.84 | 1,075 | 767.44 | 1,044 |
Advertising Expenses | - | 86.29 | 92.79 | 91.01 | 68.82 | 108.57 |